A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

BACKGROUND: Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial pote...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gupta, Pawan K, Chullikana, Anoop, Parakh, Rajiv, Desai, Sanjay, Das, Anjan, Gottipamula, Sanjay, Krishnamurthy, Sagar, Anthony, Naveen, Pherwani, Arun, Majumdar, Anish S
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3688296/
https://ncbi.nlm.nih.gov/pubmed/23758736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-143
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items